title: Introduction: Mass Spectrometry and Emerging Technologies for Biomarker Discovery in the Assessment of Human Health and Disease.
authors.affiliation: Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal SE-431 83, Sweden.
authors.forename: Emre M
authors.initials: EM
authors.lastname: Isin
authors.affiliation: Masonic Cancer Center and Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Robert J
authors.identifier: 0000-0001-7355-9903
authors.initials: RJ
authors.lastname: Turesky
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D004194:Disease; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D006262:Health; D006801:Humans; D013058:Mass Spectrometry; D004364:Pharmaceutical Preparations / Q000008:administration & dosage
chemical_list: D015415:Biomarkers; D004364:Pharmaceutical Preparations